Where you are

Two mandates. The same gap.

Emerging fund, Fund I or II

"Fund II gets raised on what Fund I can prove."

The thesis is sound and the bench is thin. You cannot staff every hold with an operating partner, and LPs are not underwriting one good outcome. The work puts a repeatable operating standard inside each company, run by the company, so the track record is a system rather than a story.

Holdco, permanent capital, OS builder

"There's no exit clock. There's also no forcing function."

A long hold removes the deadline that makes most plans move. The cadence replaces it. Compounding gets a mechanism, and the capability you build stays in the company instead of in your platform team.

If this sounds familiar

The hold rarely fails on the thesis.

"The value-creation plan is a deck nobody owns."
"The 100-day plan started strong, then fragmented."
"Our ops capability is one person across the whole portfolio."
"When the operating partner leaves the room, the capability leaves with them."
"We can show LPs good deals. We can't show them a repeatable engine."

The hold that underdelivers rarely fails on the thesis. It fails because the plan never became work the company owned, and the capability walked out with the operating partner.

Your path

The plan, owned by the company. The capability, kept to exit.

A portfolio team that owns the plan and runs it. When a firm has to keep an operating partner in the weeds, the system is what's missing; we build the system. The capability stays in the company and shows up where it counts at exit.

The decision gate

Every ninety days, the firm answers the same question.

The exit becomes a date the firm chooses, rather than one it backs into.

In practice

What it's worth when a capital partner backs it.

Membrion

Written into the term sheet. Built into the company.

Membrion is a venture-backed deep-tech company in Seattle. Its lead investor valued the operating work enough to write it into the Series B term sheet, funding the engagement out of the round's use of funds.

We installed the foundation the company had never built: mission, strategy, an investor-grade financial model, and a quarterly planning cadence the leadership team runs. In the founder's words, it was the first real foundation the company had.

Membrion went on to close its next round at roughly three times the valuation it went into the Series B on.

Venture-backed deep-tech company · investor-mandated engagement
About 3×
the next round over the Series B pre-money.
Alignment

On the same side as your LPs.

We prefer part of our compensation tied to value created rather than time spent. Most often that is participation in performance or milestone bonuses, or a form of equity in the portfolio company. Where we work across a portfolio as an embedded partner over an extended period, it can extend to the fund structure itself, as carried interest or a share of the promote. It gets named at the start, and scoped, fixed-fee work stays available where that fits the firm better.

where we start

ValueX first, then the build.

Every engagement starts with ValueX, so the work goes to the right things in the right order. Forty-five days or less, fixed fee. See ValueX ›

Start a conversation.

We'll take a straight read on where your business stands and what's in the way.

Start a conversation